Polyrocks(SH:688669) Hua Xia Shi Bao·2026-02-05 22:15Core Viewpoint - The Guangdong Securities Regulatory Commission has uncovered multiple financial fraud activities by 聚石化学, including inaccurate revenue accounting, undisclosed related party transactions, and inadequate internal controls [2][4]. Group 1: Financial Misconduct - 聚石化学 engaged in false trade activities through its subsidiary, 广东冠臻科技, resulting in inflated revenues of 86,550,865.69 yuan and inflated costs of 88,238,071.82 yuan, leading to a profit reduction of 1,687,206.13 yuan [2][3]. - Another fraudulent trade involved the company participating in a third-party trade chain, inflating both revenue and costs by 52,236,440.86 yuan, without any actual commercial substance [3]. - The company also reported inflated revenue of 18,020,070.80 yuan and costs of 17,995,752.21 yuan from sales of isooctane, which did not involve actual goods being shipped [3]. Group 2: Regulatory Actions and Penalties - The Guangdong Securities Regulatory Commission has mandated corrective actions, issued warnings, and imposed a fine of 2.4 million yuan on 聚石化学, along with penalties totaling 4.3 million yuan on four executives involved [3][4]. - The company has been ordered to improve its internal controls and enhance the quality of information disclosure to prevent future misconduct [4]. Group 3: Impact on Business and Future Outlook - 聚石化学's acquisition of 冠臻科技 has turned out to be unsuccessful, with the latter's performance deteriorating significantly post-acquisition, leading to substantial losses for 聚石化学 [5][6]. - The company anticipates a net loss of between 90 million to 120 million yuan for 2025, a stark contrast to a profit of 23,614.68 million yuan in the previous year, primarily due to the impact of the international oil market and operational challenges [6][7]. - Despite divesting 冠臻科技, 聚石化学 continues to face difficulties in returning to pre-IPO performance levels, with ongoing challenges in its diversified business operations [7].